Skip to main content
SpringerLink
Log in

The Neuromuscular Manifestations of Primary Hyperparathyroidism in Humans

  • Chapter
New Actions of Parathyroid Hormone

  • 91 Accesses

Abstract

The clinical manifestations of primary hyperparathyroidism can be of an immense spectrum from no symptomatology to the severest expression of the disease with renal stones, bone pain and fractures, gastrointestinal complaints, and neuropsychiatric manifestations. It is the purpose of this discussion to focus on the neuromuscular manifestations of hyperparathyroidism and to see whether parathyroid hormone (PTH) by itself or the other biochemical alterations induced by increased circulating levels of PTH, such as hypercalcemia or hypophosphatemia, can be implicated in the neuromuscular aberrations attributed to hyperparathyroidism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rabin, D., T.J. McKenna, 1982, Clinical Endocrinology and Metabolism. 672p. Grune Publisher, New York.

    Google Scholar 

  2. Vicale, C.T., 1949. The diagnostic features of a muscular syndrome resulting from hyperparathyroidism, osteomalacia owing to renal tubular acidosis, and perhaps related disorders of calcium metabolism. Trans. Amer. Neurological Assoc. 74: 143.

    Google Scholar 

  3. Smith, R., G. Stern, 1967. Myopathy, osteomalacia and hyperparathyroidism. Brain 90: 593.

    Article  PubMed  CAS  Google Scholar 

  4. Caughey, J.E., G. Parendeh, L.B. Cohen, M. Vameghi, 1971. Multiple endocrine adenomatosis with metabolic myopathy. N.Z. Med. J. 74: 18.

    Google Scholar 

  5. Cape, C.A., 1971. Increased Phosphorylase activity in muscle in hyperparathyroid disease. Neurology 21: 638.

    PubMed  CAS  Google Scholar 

  6. Goodhue, W.W., J.N. Davis, R.S. Porro, 1972. Ischemic myopathy in uremic hyperparathyroidism. JAMA 221: 911.

    Article  PubMed  CAS  Google Scholar 

  7. Hines, J.R., J.R. Suker, 1973. Some unusual manifestations of parathyroid disease. Surg. Clinics of No. Am. 53: 221.

    CAS  Google Scholar 

  8. Aurbach, G.D., L.E. Mallette, B.M. Patten, D.A. Heath, J.L. Doppman, J.P. Bilezikian, 1973. Hyperparathyroidism: recent studies. Ann.Int. Med. 79: 566.

    Google Scholar 

  9. Caplan, R.H., K.C. Bogart, 1974. Myopathy in primary hyperparathyroidism. Wise. Med. J. 73: 527.

    Google Scholar 

  10. Soucie, J., 1974. Letter: Hypercalcemia and neuromuscular disease. Ann. Int. Med. 81: 128.

    Google Scholar 

  11. Tashima, C.K., 1974. Letter: Hypercalcemia and neuromuscular disease. Ann. Int. Med. 81: 129.

    Google Scholar 

  12. Patten, B.M., J.P. Bilezikian, L.E. Mallette, A. Prince, W.K. Engle, G.D. Aurbach, 1974. Neuromuscular disease in primary hyperparathyroidism. Ann. Int. Med. 80: 182.

    PubMed  CAS  Google Scholar 

  13. Gerster, J.C., T.L. Vischer, A. Panchaud, P. Burchhardt, E. Courvoisier, G.H. Fallet, 1975. Myalgies dans 1’hyperparathyroidie primaire: un diagnostic differentiel de la polymyalgia rheumatica. Schweiz. Med. Wschr. 105: 623.

    PubMed  CAS  Google Scholar 

  14. Rollinson, R.D., B.S. Gilligan, 1977. Primary hyperparathyroidism presenting as a proximal myopathy. Aust. N.Z. J. Med. 7: 420.

    PubMed  CAS  Google Scholar 

  15. Kaplan, P.E., J.R. Hines, J.E. Leestma, H.J. Ruder, 1980. Neuromuscular junction transmission deficit in a patient with primary hyperparathyroidism. Electromyog. Clin Neurophysiol. 20: 359.

    CAS  Google Scholar 

  16. Kaplan, P.E., H.J. Ruder, J.R. Hines, 1982. Neuromuscular junction dysfunction in primary hyperparathyroidism: A new hypothesis. Electromyog. Clin. Neurophysiol. 22: 239.

    CAS  Google Scholar 

  17. Tibblin, S., N. Palsson and J. Rydberg, 1983. Hyperparathyroidism in the lederly. Ann. Surg. 197: 135.

    Article  PubMed  CAS  Google Scholar 

  18. Ljunghall, S., G. Akerstrom, G. Johansson, Y. Olsson, E. Stalberg, 1984. Neuromuscular involvement in primary hyperparathyroidism. J. Neurology 231: 263.

    Article  CAS  Google Scholar 

  19. Yalowitz, D.L., A.S. Brett, J.M. Earll, 1984. Far-advanced primary hyperparathyroidism in an 18-year-old man. Am. J. Med. 77: 545.

    Article  PubMed  CAS  Google Scholar 

  20. Wersall-Robertson, E., B. Hamberger, H. Ehren, E. Eriksson and P.O. Granberg, 1986. Increase in muscular strength following surgery for primary hyperparathyroidism. Acta. Med. Scan. 220: 233.

    CAS  Google Scholar 

  21. Barr, D., P. Bulger, Amer. J. Med. Sc. 179: 449, 1930.

    Google Scholar 

  22. Prineas, J.W., A.S. Mason, R.A. Hanson, 1965. Myopathy in metabolic bone disease. Br. Med. J. 1: 1034.

    Google Scholar 

  23. Bischoff, A., E. Esslen, 1965. Myopathy with primary hyperparathyroidism. Neurology 15: 64.

    PubMed  CAS  Google Scholar 

  24. Frame, B., E.G. Heinze, Jr., M.A. Block and G.A. Manson, 1968. Myopathy in primary hyperparathyroidism. Observations in three patients. Ann. Int. Med. 68: 1022.

    PubMed  CAS  Google Scholar 

  25. Cholod, E.J., M.D. Haust, A.J. Hudson, F.N. Lewis, 1970. Myopathy in primary familial hyperparathyroidism. Am. J. Med. 48: 700.

    Article  PubMed  CAS  Google Scholar 

  26. Kendall-Taylor, P., D.M. Turnbull, 1983. Endocrine myopathies. Br. Med. J. 287: 705.

    Article  CAS  Google Scholar 

  27. Mallette, L.E., B.M. Patten, W.K. Engel, 1975. Neuromuscular disease in secondary hyperparathyroidism. Ann. Int. Med. 82: 474.

    PubMed  CAS  Google Scholar 

  28. Brautbar, N., C.R. Kleeman, 1987. Hypophosphatemia and hyperphosphatemia: clinical and pathophysiologic aspects. In Clinical Disorders of Fluid and Electrolyte Metabolism. Eds. M.H. Maxwell, C.R. Kleeman, R.G. Narins, 4th Ed. McGraw Hill Book Co., New York, pp. 789.

    Google Scholar 

  29. Pessah, M., W. Frank, 1974. Letter: hyperparathyroidism and renal tubular acidosis. Ann. Int. Med. 80: 116.

    PubMed  CAS  Google Scholar 

  30. Ginn, H.E., L.L. Shanbour, 1967. Phosphaturia in magnesium-deficient rats. Am. J. Physiol. 212: 1347.

    Google Scholar 

  31. Shils, M.E., 1969. Experimental human magnesium depletion. Medicine (Baltimore) 48: 61.

    Article  CAS  Google Scholar 

  32. Ekbom, K., R. Hed, L. Kirstein, K.E. Astrom, 1965. Weakness of proximal limb muscles, probably due to myopathy after partial gastrectomy. Acta Medica Scan. 176: 493.

    Article  Google Scholar 

  33. Thage, O., 1970. Metabolic neuropathies and myopathies in adults. Clinical aspects. Acta Neuro. Scand. 46 (Suppl. 43): 120.

    Google Scholar 

  34. Kleeman, CR., K. Norris, J.W. Coburn, 1987. Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient? Min. Elee. Metab. 13: 305.

    CAS  Google Scholar 

  35. Goldstein, D.A., L.A. Chui, S.G. Massry, 1978. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity. J. Clin. Invest. 62: 88.

    Article  PubMed  CAS  Google Scholar 

  36. Fräser, CL., p. Sarnacki, 1987. Parathyroid hormone facilitates calcium transport in rat brain synaptosomes by cAMP independent pathway. Kidney Int. 31: 347A.

    Google Scholar 

  37. Blaustein, M.P., 1975. Effects of potassium, veratridine and scorpion venom on calcium accumulation and transmitter release by nerve terminals in vitro. J. Physiol. 247: 617.

    PubMed  CAS  Google Scholar 

  38. Nachshen, D.A., 1985. Regulation of cytosolic calcium concentration in presynaptic nerve endings isolated from rat brain. J. Physiol. 363: 87.

    PubMed  CAS  Google Scholar 

  39. Sacktor, B., H. Hanai, M. Ishida and C.T. Liang, 1986. Action of PTH on Na+-Ca2+ exchange in isolated renal cells. Kidney Int. 29: 171A.

    Google Scholar 

  40. Chow, S.Y., Y.C. Chow, W.S.S. Jee, D.M. Woodbury, 1984. Electro-physiological properties of osteoblast-like cells from the cortical endosteal surface of rabbit long bones. Calcif. Tissue Int. 36: 401.

    Article  CAS  Google Scholar 

  41. Bogin, E., S.G. Massry, I. Harary, 1981. Effect of parathyroid hormone on rat heart cells. J. Clin. Invest. 67: 1215.

    Article  PubMed  CAS  Google Scholar 

  42. Massry, S.G., D.A. Goldsteion, M. Akmal, E. Gogin. The role of parathyroid hormone as a uremic toxin. In: 12th Annual Contractors Conference, Artificial kidney — Chronic Uremia Program, 1979, p. 49.

    Google Scholar 

  43. Wassner, S.J., J.B. Li, 1987. Lack of acute effect of parathyroid hormone within skeletal muscle. Int. J. Ped. Neph. 8: 15.

    CAS  Google Scholar 

  44. Baran, D.T., M.L. Milne, 1986. 1,25 dihydroxyvitamin D increases hepatocyte cytosolic calcium levels,. A potential regulator of vitamin D-25-hydroxylase. J. Clin. Invest. 77: 1622.

    Google Scholar 

  45. Fullmer, CS., M.E. Brindak, S. Edelstein, R.H. Wasserman, 1984. Early and direct effect of

    PubMed  CAS  Google Scholar 

  46. Edelman, A., CL. Thil, M. Garadedian, T. Anagnostopoulos, S. Balsan, 1983. Genome-independent effects of 1,25 dihydroxyvitamin D-3 on membrane potential. Biochem. Biophys. Acta 732: 300.

    Article  PubMed  CAS  Google Scholar 

  47. Edelman, A., C.L. Thil, M. Garabedian, J.J. Plachot, H. Guillozo, J. Fritsch, S.R. Thomas, S. Balsan, 1985. Vitamin D metabolite effects on membrane potential and intracellular potassiuim activity in rabbit cartilage. Min. Elee. Metrab. 11: 97.

    CAS  Google Scholar 

  48. Yamaguchi, D.T., T.J. Hahn, A. Iida-Klein, CR. Kleeman, S. Muallem, 1987. Parathyroid hormone-activated calcium channels in an osteoblast-like osteosarcoma cell line: cAMP-dependent and cAMP-independent calcium channels. J. Biol. Chem. 262: 7711.

    PubMed  CAS  Google Scholar 

  49. Catherwood, B.D., 1985. 1,25-dihydroxycholecalciferol and glucocorticosteroid regulation of adenylate cyclase in an osteoblast-like cell line. J. Biol. Chem. 260:736–743.

    Google Scholar 

  50. Lieberherr, M. Garabedian, H. Guillozo, C.L. Thil, S. Balsan, 1980. In vitro effect of vitamin D3 metabolites on rat calvaría cAMP content. Calcif. Tissue Int. 30: 209.

    Article  CAS  Google Scholar 

  51. Dziak, R., 1978. Effects of vitamin D3 metabolites on bone cell calcium transport. Calcif. Tissue Int. 26: 65.

    CAS  Google Scholar 

  52. Shanes, A.M., 1968. Electrochemical aspects of physiological and pharmacological action in excitable cells II the action potential and excitation. Pharmacol. Rev. 10: 165.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical and Research Services, Veterans Administration Medical Center, West Los Angeles, The Research Institute, Cedars-Sinai Medical Center, Division of Nephrology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA

    Dean T. Yamaguchi & Charles R. Kleeman

Authors
  1. Dean T. Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles R. Kleeman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Southern California, Los Angeles, California, USA

    Shaul G. Massry

  2. Kobe University School of Medicine, Kobe, Japan

    Takuo Fujita

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Yamaguchi, D.T., Kleeman, C.R. (1989). The Neuromuscular Manifestations of Primary Hyperparathyroidism in Humans. In: Massry, S.G., Fujita, T. (eds) New Actions of Parathyroid Hormone. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0567-5_42

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0567-5_42

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-7870-2

  • Online ISBN: 978-1-4613-0567-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation